The pathophysiological mechanism underlying the edema formation is shared between HAE and AAE: insufficient C1-inhibitor activity leads to uncontrolled kallikrein activation, with subsequent overproduction of bradykinin. The gene discussed is SERPING1; the disease is hereditary angioedema.